These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1808761)

  • 1. An evaluation of prothrombin assay method using MD805 by means of warfarin-treated plasma.
    Hijikata-Okunomiya A; Funahara Y; Opartkiattikul N
    Thromb Res; 1991 Dec; 64(5):559-69. PubMed ID: 1808761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new method for the determination of prothrombin in human plasma.
    Hijikata-Okunomiya A
    Thromb Res; 1990 Mar; 57(5):705-15. PubMed ID: 2339365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of acarboxy prothrombin (PIVKA-II) and coagulation factors in warfarin-treated patients.
    Umeki S; Umeki Y
    Med Lab Sci; 1990 Apr; 47(2):103-7. PubMed ID: 2381266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of plasma prothrombin level by Ca2+-dependent prothrombin activator (CA-1) during warfarin anticoagulation.
    Iwahashi H; Kimura M; Nakajima K; Yamada D; Morita T
    J Heart Valve Dis; 2001 May; 10(3):388-92. PubMed ID: 11380105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a new laboratory test to evaluate antithrombin resistance in plasma.
    Murata M; Takagi A; Suzuki A; Okuyama E; Takagi Y; Ando Y; Kato I; Nakamura Y; Murate T; Matsushita T; Saito H; Kojima T
    Thromb Res; 2014 Feb; 133(2):293-8. PubMed ID: 24325876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
    Choi Q; Kim JE; Hyun J; Han KS; Kim HK
    Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy.
    Jonsson M; Hillarp A; Svensson P
    Thromb Res; 2004; 114(2):83-9. PubMed ID: 15306149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a synthetic thrombin-inhibitor MD805 on the reaction between thrombin and plasma antithrombin-III.
    Hijikata-Okunomiya A; Okamoto S; Wanaka K
    Thromb Res; 1990 Sep; 59(6):967-77. PubMed ID: 2264021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of oral anticoagulant therapy by measuring plasma prothrombin fragment 1 + 2.
    Takahashi H; Wada K; Satoh N; Takakuwa E; Furuta R; Yoshino N; Shibata A
    Blood Coagul Fibrinolysis; 1993 Jun; 4(3):435-9. PubMed ID: 8329570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotest mixing experiments in congenital coagulation disorders of the prothrombin complex and in coumarin treated patients. An additional evidence against the presence of an inhibitor in the latter.
    Girolami A; Patrassi O; Cella G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(3):463-70. PubMed ID: 72033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The technique of measuring thrombin generation with fluorogenic substrates: 3. The effects of sample dilution.
    De Smedt E; Wagenvoord R; Coen Hemker H
    Thromb Haemost; 2009 Jan; 101(1):165-70. PubMed ID: 19132204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Some aspects of newly developed instruments for blood coagulation tests].
    Matsuo T; Kario K
    Rinsho Byori; 1995 Dec; 43(12):1209-13. PubMed ID: 8569030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point of care monitoring of oral anticoagulant therapy in children: comparison of CoaguChek Plus and Thrombotest methods with venous international normalised ratio.
    Ignjatovic V; Barnes C; Newall F; Hamilton S; Burgess J; Monagle P
    Thromb Haemost; 2004 Oct; 92(4):734-7. PubMed ID: 15467903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation.
    Koefoed BG; Feddersen C; Gulløv AL; Petersen P
    Thromb Haemost; 1997 May; 77(5):845-8. PubMed ID: 9184390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between prothrombin activation fragment (F1.2), cerebral ischemia (S-100beta) and international normalized ratio (INR) in patients with ventricular assisted devices.
    Joshi A; Magder LS; Kon Z; Kallam S; Kwon M; Sangrampurkar R; Pierson R; Poston R
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):323-7. PubMed ID: 17669856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Laboratory assessment of haemostatic parameters in patients taking a direct thrombin inhibitor].
    Beliavskaia OO; Vavilova TV
    Angiol Sosud Khir; 2014; 20(4):37-41. PubMed ID: 25490355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
    Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
    Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel clotting assay for quantitation of plasma prothrombin (factor II) using Echis multisquamatus venom.
    Petrovan RJ; Rapaport SI; Le DT
    Am J Clin Pathol; 1999 Nov; 112(5):705-11. PubMed ID: 10549258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional quality control of coagulation assay procedures (normotest, simplastin-a and thrombotest).
    Kahan J
    Thromb Diath Haemorrh; 1974 Sep; 32(1):79-89. PubMed ID: 4454048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombin.antithrombin III complex].
    Matsuo T; Kario K; Matsuo M
    Rinsho Byori; 1991 Jul; 39(7):701-6. PubMed ID: 1920862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.